More recent clinical trial results show AstraZeneca’s COVID-19 vaccine is slightly less effective in stopping disease than the company first reported.
Author: Karen Weintraub, USA TODAY
Moncef Slaoui, former Operation Warp Speed science chief, fired by drugmaker GSK for sexual harassment
Moncef Slaoui, a former head of Operation Warp Speed, who spearheaded COVID-19 vaccine development in the USA, was fired by GSK for harassing an employee.
‘It’s easy to scare people’: Europe’s decision to pull AstraZeneca-Oxford vaccine threatens global COVID-19 recovery efforts, US experts say
As AstraZeneca defends its COVID-19 vaccine following a European pause, the World Health Organization says there is no reason to stop using it.
Johnson & Johnson COVID-19 vaccine, which requires just one shot, is on track to become third allowed for use in US
The Food and Drug Administration is expected to act quickly to authorize J&J’s one-dose COVID-19 vaccine after an advisory panel meets Friday.
Moderna to begin trial of new COVID vaccine to address virus variant first found in South Africa
Moderna’s trial of a new COVID-19 vaccine will target the virus variant that first emerged in South Africa. Other vaccine makers plan similar studies.
Why get COVID-19 vaccination if you still have to wear a mask? It beats getting sick, health experts say.
Getting two shots of either the Moderna or Pfizer-BioNTech vaccine reduces risk of developing symptomatic COVID-19 by about 95%, but not completely.
‘This has to be the moment’ to invest in coronavirus vaccines and treatments against future pandemics, experts warn
A growing chorus of researchers say now is the time to invest in coronavirus vaccine development and treatments to stop the next pandemic to come.
‘We need to be prepared’: FDA will draft guidance to work with vaccine, drug and testing companies on COVID-19 variants
FDA plans to develop guidance to help COVID-19 vaccine, drug and testing manufacturers adapt to emerging variants of the SARS-CoV-2 virus.
Novavax’s COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial, also provided a range of immunity against new variants
The Novavax vaccine candidate also appears to have mixed levels of effectiveness against coronavirus variants.
The first 22M Americans have been vaccinated for COVID-19, and initial safety data shows everything is going well, CDC says
Side effects remain a common result of the Pfizer-BioNTech and Moderna coronavirus vaccines: 70% of people who self-reported say they suffered pain.